chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Rash pruritic, Vaccination site rash
Clinical narrative: Rash is itchy; Rash near the injection site which is size of a softball; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Rash is itchy) and VACCINATION SITE RASH (Rash near the injection site which is size of a softball) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced RASH PRURITIC (Rash is itchy) and VACCINATION SITE RASH (Rash near the injection site which is size of a softball). At the time of the report, RASH PRURITIC (Rash is itchy) and VACCINATION SITE RASH (Rash near the injection site which is size of a softball) outcome was unknown.            No concomitant medications were used by patient.  No treatment medications. were used by patient.  Action taken with mRNA-1273 in response to the event was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Follow-up information received on 28-MAY-2021, had updated address.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose, Cough, Decreased appetite, Dry mouth, Myalgia
Clinical narrative: Dry mouth; No appetite; Mild cough; Nausea; Muscle aches began radiating throughout the body, starting in legs and moving to upper body; Injection site discomfort; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (Injection site discomfort), DRY MOUTH (Dry mouth), DECREASED APPETITE (No appetite), COUGH (Mild cough) and NAUSEA (Nausea) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced VACCINATION SITE DISCOMFORT (Injection site discomfort) and MYALGIA (Muscle aches began radiating throughout the body, starting in legs and moving to upper body). On an unknown date, the patient experienced DRY MOUTH (Dry mouth), DECREASED APPETITE (No appetite), COUGH (Mild cough) and NAUSEA (Nausea). At the time of the report, VACCINATION SITE DISCOMFORT (Injection site discomfort), DRY MOUTH (Dry mouth), DECREASED APPETITE (No appetite), COUGH (Mild cough), NAUSEA (Nausea) and MYALGIA (Muscle aches began radiating throughout the body, starting in legs and moving to upper body) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Blood glucose: elevated (High) Increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.   No treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow-up contains route of suspect drug administration was updated
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vaccination site discomfort
Clinical narrative: Dry mouth; No appetite; Mild cough; Nausea; Muscle aches began radiating throughout the body, starting in legs and moving to upper body; Injection site discomfort; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOMFORT (Injection site discomfort), DRY MOUTH (Dry mouth), DECREASED APPETITE (No appetite), COUGH (Mild cough) and NAUSEA (Nausea) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced VACCINATION SITE DISCOMFORT (Injection site discomfort) and MYALGIA (Muscle aches began radiating throughout the body, starting in legs and moving to upper body). On an unknown date, the patient experienced DRY MOUTH (Dry mouth), DECREASED APPETITE (No appetite), COUGH (Mild cough) and NAUSEA (Nausea). At the time of the report, VACCINATION SITE DISCOMFORT (Injection site discomfort), DRY MOUTH (Dry mouth), DECREASED APPETITE (No appetite), COUGH (Mild cough), NAUSEA (Nausea) and MYALGIA (Muscle aches began radiating throughout the body, starting in legs and moving to upper body) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In April 2021, Blood glucose: elevated (High) Increased.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.   No treatment medication was provided.   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow-up contains route of suspect drug administration was updated
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: Right arm turned fire red from shoulder to elbow; Itchiness on back, shoulders and top of chest; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA and PRURITUS in an 89-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA and PRURITUS. At the time of the report, ERYTHEMA and PRURITUS outcome was unknown.            The patient called to report that they received their 2nd dose of the Moderna vaccine, and their right arm turned fire red from shoulder down to their elbow. The patient also had itchiness on their back, shoulders and top of chest.  No Concomitant product use was reported. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary pain, Dyspepsia, Eructation, Pain in extremity
Clinical narrative: pain in arms; heartburn; burping; pain in armpits; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in arms), DYSPEPSIA (heartburn), ERUCTATION (burping) and AXILLARY PAIN (pain in armpits) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in arms), DYSPEPSIA (heartburn), ERUCTATION (burping) and AXILLARY PAIN (pain in armpits). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (pain in arms), DYSPEPSIA (heartburn), ERUCTATION (burping) and AXILLARY PAIN (pain in armpits) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   The patient stated that the events has been on and off since,especially if he was exerting himself.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Swelling of eyelid
Clinical narrative: eye lid swollen; rash on right arm that was spreading; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING OF EYELID (eye lid swollen) and RASH (rash on right arm that was spreading) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Adverse event.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, the patient experienced RASH (rash on right arm that was spreading). On 10-Apr-2021, the patient experienced SWELLING OF EYELID (eye lid swollen). On 12-Apr-2021, SWELLING OF EYELID (eye lid swollen) had resolved. At the time of the report, RASH (rash on right arm that was spreading) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported..
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Vertigo
Clinical narrative: vertigo; This spontaneous case was reported by a consumer and describes the occurrence of VERTIGO (vertigo) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VERTIGO (vertigo). At the time of the report, VERTIGO (vertigo) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported. Upon internal review on 04-Aug-2021, the age was corrected to 65 years.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain upper, Sleep disorder
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (stomach cramps) and SLEEP DISORDER (disturbed sleep) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination. No Medical History information was reported. On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 07-Apr-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach cramps) and SLEEP DISORDER (disturbed sleep). At the time of the report, ABDOMINAL PAIN UPPER (stomach cramps) and SLEEP DISORDER (disturbed sleep) outcome was unknown. Treatment details not provided. concomitant product details not provided.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site pruritus, Vaccination site warmth
Clinical narrative: migraine; Vaccination site pruritus; Vaccination site erythema; vaccination site discoloration; Vaccination site mass; Burning sensation; Vaccination site warmth; Vaccination site tenderness; Vaccination site erythema; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Burning sensation), VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE DISCOLOURATION (vaccination site discoloration), VACCINATION SITE MASS (Vaccination site mass) and MIGRAINE (migraine) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046a21a and 047B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy (Unspecified allergies.) since 03-Jan-2018, Diabetes since 05-Jan-2017 and Hypertension since 05-Jan-2017. Concomitant products included CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Allergy, MULTIVITAMINS [VITAMINS NOS] from 01-Jan-2007 to an unknown date and MULTIVITAMIN ACTIVE WOMAN from 01-Jan-2013 to an unknown date for an unknown indication.   On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced BURNING SENSATION (Burning sensation), VACCINATION SITE WARMTH (Vaccination site warmth), VACCINATION SITE PAIN (Vaccination site tenderness) and the first episode of VACCINATION SITE ERYTHEMA (Vaccination site erythema). On 16-Apr-2021, the patient experienced VACCINATION SITE DISCOLOURATION (vaccination site discoloration), VACCINATION SITE MASS (Vaccination site mass), VACCINATION SITE PRURITUS (Vaccination site pruritus) and the second episode of VACCINATION SITE ERYTHEMA (Vaccination site erythema). On an unknown date, the patient experienced MIGRAINE (migraine). The patient was treated with HYDROCORTISONE for Itch, at a dose of 1 dosage form and PARACETAMOL (TYLENOL) for Migraine, at a dose of 1 dosage form once a day. On 12-Apr-2021, BURNING SENSATION (Burning sensation) and VACCINATION SITE WARMTH (Vaccination site warmth) had resolved, VACCINATION SITE PAIN (Vaccination site tenderness) was resolving. On 19-Apr-2021, VACCINATION SITE DISCOLOURATION (vaccination site discoloration), VACCINATION SITE MASS (Vaccination site mass) and VACCINATION SITE PRURITUS (Vaccination site pruritus) had resolved, last episode of VACCINATION SITE ERYTHEMA (Vaccination site erythema) was resolving. At the time of the report, MIGRAINE (migraine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Most recent FOLLOW-UP information incorporated above includes: On 28-May-2021: Patient demographics added, concomitant medication added, event out come updated, historical condition of the patient updated, 2nd dose information updated.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthritis, Gait disturbance, Musculoskeletal stiffness, Myalgia, Nausea
Clinical narrative: trouble walking; knees are stiff; arthritis "all of a sudden; fingers feel a little stiff; the aches affect the walking; pain in the arm of the injection; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (trouble walking), MUSCULOSKELETAL STIFFNESS (knees are stiff), ARTHRITIS (arthritis "all of a sudden), MUSCULOSKELETAL STIFFNESS (fingers feel a little stiff) and VACCINATION SITE PAIN (pain in the arm of the injection) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The medical history was not provided by the reporter.     On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain in the arm of the injection) and NAUSEA (Nausea). On 05-Apr-2021, the patient experienced GAIT DISTURBANCE (trouble walking), MUSCULOSKELETAL STIFFNESS (knees are stiff), ARTHRITIS (arthritis "all of a sudden), MUSCULOSKELETAL STIFFNESS (fingers feel a little stiff) and MYALGIA (the aches affect the walking). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. On 29-Mar-2021, VACCINATION SITE PAIN (pain in the arm of the injection) and NAUSEA (Nausea) had resolved. At the time of the report, GAIT DISTURBANCE (trouble walking), MUSCULOSKELETAL STIFFNESS (knees are stiff), ARTHRITIS (arthritis "all of a sudden), MUSCULOSKELETAL STIFFNESS (fingers feel a little stiff) and MYALGIA (the aches affect the walking) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Lab data include an X-RAY and it looks like patient has arthritis Concomitant medications include Blood pressure medications Treatment include ice/heat on the knees.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: trouble walking; knees are stiff; arthritis "all of a sudden; fingers feel a little stiff; the aches affect the walking; pain in the arm of the injection; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of GAIT DISTURBANCE (trouble walking), MUSCULOSKELETAL STIFFNESS (knees are stiff), ARTHRITIS (arthritis "all of a sudden), MUSCULOSKELETAL STIFFNESS (fingers feel a little stiff) and VACCINATION SITE PAIN (pain in the arm of the injection) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 018B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The medical history was not provided by the reporter.     On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, the patient experienced VACCINATION SITE PAIN (pain in the arm of the injection) and NAUSEA (Nausea). On 05-Apr-2021, the patient experienced GAIT DISTURBANCE (trouble walking), MUSCULOSKELETAL STIFFNESS (knees are stiff), ARTHRITIS (arthritis "all of a sudden), MUSCULOSKELETAL STIFFNESS (fingers feel a little stiff) and MYALGIA (the aches affect the walking). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. On 29-Mar-2021, VACCINATION SITE PAIN (pain in the arm of the injection) and NAUSEA (Nausea) had resolved. At the time of the report, GAIT DISTURBANCE (trouble walking), MUSCULOSKELETAL STIFFNESS (knees are stiff), ARTHRITIS (arthritis "all of a sudden), MUSCULOSKELETAL STIFFNESS (fingers feel a little stiff) and MYALGIA (the aches affect the walking) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Lab data include an X-RAY and it looks like patient has arthritis Concomitant medications include Blood pressure medications Treatment include ice/heat on the knees.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Heart rate increased, Illness, Nausea
Clinical narrative: Elevated heart rate; Was sick as a dog; Left arm was killing her; Fever; Headache; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Elevated heart rate), ILLNESS (Was sick as a dog), PAIN IN EXTREMITY (Left arm was killing her), PYREXIA (Fever) and HEADACHE (Headache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced ILLNESS (Was sick as a dog), PAIN IN EXTREMITY (Left arm was killing her), PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea). On 08-Apr-2021, the patient experienced HEART RATE INCREASED (Elevated heart rate). At the time of the report, HEART RATE INCREASED (Elevated heart rate), ILLNESS (Was sick as a dog), PAIN IN EXTREMITY (Left arm was killing her), PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.            Action taken with respect to m-RNA1273 was considered to be not applicable.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Elevated heart rate; Was sick as a dog; Left arm was killing her; Fever; Headache; Chills; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (Elevated heart rate), ILLNESS (Was sick as a dog), PAIN IN EXTREMITY (Left arm was killing her), PYREXIA (Fever) and HEADACHE (Headache) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025821A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Apr-2021, the patient experienced ILLNESS (Was sick as a dog), PAIN IN EXTREMITY (Left arm was killing her), PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea). On 08-Apr-2021, the patient experienced HEART RATE INCREASED (Elevated heart rate). At the time of the report, HEART RATE INCREASED (Elevated heart rate), ILLNESS (Was sick as a dog), PAIN IN EXTREMITY (Left arm was killing her), PYREXIA (Fever), HEADACHE (Headache), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown.            Action taken with respect to m-RNA1273 was considered to be not applicable.
Age: 35.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Expired drug administration; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired drug administration) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 020B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 08-Apr-2021 at 10:15 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021 at 10:15 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired drug administration). On 08-Apr-2021, EXPIRED PRODUCT ADMINISTERED (Expired drug administration) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  Treatment information was not provided.     Most recent FOLLOW-UP information incorporated above includes: On 16-Apr-2021: Patient demographics and dose details were updated.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Fatigue, Pain in extremity, SARS-CoV-2 test
Clinical narrative: Arm did hurt but not severely; Kind of tired; Positive for Covid-19 infection; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm did hurt but not severely), COVID-19 (Positive for Covid-19 infection) and FATIGUE (Kind of tired) in a 57-year-old female adult exposed to mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) , while the parent received the product for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the parent received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 22-Mar-2021, the adult was diagnosed with COVID-19 (Positive for Covid-19 infection). On an unknown date, the adult was diagnosed with PAIN IN EXTREMITY (Arm did hurt but not severely) and FATIGUE (Kind of tired). The adult was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Arm did hurt but not severely), COVID-19 (Positive for Covid-19 infection) and FATIGUE (Kind of tired) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Mar-2021, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Body temperature, Dizziness, Heart rate, Hyperhidrosis
Clinical narrative: dizziness; sweating; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (dizziness) and HYPERHIDROSIS (sweating) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021 at 8:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021 at 8:50 AM, the patient experienced DIZZINESS (dizziness) and HYPERHIDROSIS (sweating). On 08-Apr-2021 at 10:14 AM, DIZZINESS (dizziness) and HYPERHIDROSIS (sweating) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Blood pressure measurement (120-80 mmHg): 140/98 mmHg (High) 08:50 am (20 min after vaccination) and 120/82 mmHg (normal) 10:14 am (prior leaving the facility). On 08-Apr-2021, Body temperature (97.7-99.5): 98.0  degree fahrenheit (normal) 08:50 am (20 min after vaccination) and 98.0  degree fahrenheit (normal) 10:14 am (prior leaving the facility). On 08-Apr-2021, Heart rate (60-100): 62 beats per minute (normal) 08:50 am (20 min after vaccination) and 57 beats per minute (Low) 10:14 am (prior leaving the facility). On 08-Apr-2021, Oxygen saturation (96-100): 98% (normal) 08:50 am (20 min after vaccination) and 97% (normal) 10:14 am (prior leaving the facility).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reported.  Patient was monitored for 1 hour and 25 minutes by one of  registered nurses.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Followup received: contains no new information. On 19-Jul-2021: Significant FU : Patient details provided
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Oxygen saturation
Clinical narrative: dizziness; sweating; This spontaneous case was reported by a nurse and describes the occurrence of DIZZINESS (dizziness) and HYPERHIDROSIS (sweating) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039K20A) for COVID-19 vaccination.     No Medical History information was reported.    On 08-Apr-2021 at 8:30 AM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021 at 8:50 AM, the patient experienced DIZZINESS (dizziness) and HYPERHIDROSIS (sweating). On 08-Apr-2021 at 10:14 AM, DIZZINESS (dizziness) and HYPERHIDROSIS (sweating) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-Apr-2021, Blood pressure measurement (120-80 mmHg): 140/98 mmHg (High) 08:50 am (20 min after vaccination) and 120/82 mmHg (normal) 10:14 am (prior leaving the facility). On 08-Apr-2021, Body temperature (97.7-99.5): 98.0  degree fahrenheit (normal) 08:50 am (20 min after vaccination) and 98.0  degree fahrenheit (normal) 10:14 am (prior leaving the facility). On 08-Apr-2021, Heart rate (60-100): 62 beats per minute (normal) 08:50 am (20 min after vaccination) and 57 beats per minute (Low) 10:14 am (prior leaving the facility). On 08-Apr-2021, Oxygen saturation (96-100): 98% (normal) 08:50 am (20 min after vaccination) and 97% (normal) 10:14 am (prior leaving the facility).     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided by the reported.  Patient was monitored for 1 hour and 25 minutes by one of  registered nurses.   Most recent FOLLOW-UP information incorporated above includes: On 18-Jun-2021: Followup received: contains no new information. On 19-Jul-2021: Significant FU : Patient details provided
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Antinuclear antibody, Body temperature, Headache, Pyrexia, Rash
Clinical narrative: Fever for days(102 to 103F); Headache which lasted about 72 hours; Rash on face (Intermittent); This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever for days(102 to 103F)), HEADACHE (Headache which lasted about 72 hours) and RASH (Rash on face (Intermittent)) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced PYREXIA (Fever for days(102 to 103F)), HEADACHE (Headache which lasted about 72 hours) and RASH (Rash on face (Intermittent)). On 14-Mar-2021, PYREXIA (Fever for days(102 to 103F)) and HEADACHE (Headache which lasted about 72 hours) had resolved. At the time of the report, RASH (Rash on face (Intermittent)) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Mar-2021, Body temperature: 102-103 (High) 102 to 103F. On an unknown date, Antinuclear antibody: positive (Positive) ANA positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 13-May-2021: Non Significant F/U Case Email ID Add.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymph node pain, Neck pain
Clinical narrative: lymph node or thyroid on the right side of neck started hurting; headache; neck tenderness since after receiving the first dose; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (neck tenderness since after receiving the first dose), LYMPH NODE PAIN (lymph node or thyroid on the right side of neck started hurting) and HEADACHE (headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     The patient's past medical history included Parkinson's disease. Concomitant products included CARBIDOPA MONOHYDRATE, LEVODOPA (SINEMET) and ALPRAZOLAM (XANAX) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced NECK PAIN (neck tenderness since after receiving the first dose). On an unknown date, the patient experienced LYMPH NODE PAIN (lymph node or thyroid on the right side of neck started hurting) and HEADACHE (headache). At the time of the report, NECK PAIN (neck tenderness since after receiving the first dose) had not resolved and LYMPH NODE PAIN (lymph node or thyroid on the right side of neck started hurting) and HEADACHE (headache) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 24-Jun-2021: Follow-up received on the date 24-JUN-2021 was non significant. On 16-Jul-2021: Follow up included additional events
Sex: M
Vaccine: COVID19
Symptoms: Dysgeusia, Pruritus, Urticaria
Clinical narrative: hives/welts; top lip gets fat and he gets a metallic taste in his mouth when he feels the hives coming out; hives are very itchy and welts; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (hives/welts), DYSGEUSIA (top lip gets fat and he gets a metallic taste in his mouth when he feels the hives coming out) and PRURITUS (hives are very itchy and welts) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced URTICARIA (hives/welts), DYSGEUSIA (top lip gets fat and he gets a metallic taste in his mouth when he feels the hives coming out) and PRURITUS (hives are very itchy and welts). The patient was treated with CORTISONE at a dose of 2 shots; PREDNISONE at an unspecified dose and frequency; FEXOFENADINE HYDROCHLORIDE (ALLEGRA) at an unspecified dose and frequency and CETIRIZINE HYDROCHLORIDE (BENADRYL ALLERGY [CETIRIZINE HYDROCHLORIDE]) at an unspecified dose and frequency. At the time of the report, URTICARIA (hives/welts), DYSGEUSIA (top lip gets fat and he gets a metallic taste in his mouth when he feels the hives coming out) and PRURITUS (hives are very itchy and welts) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Sore arm; This spontaneous case was reported by a non-health professional and describes the occurrence of MYALGIA (Sore arm) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     The patient's past medical history included Stroke (lead to left arm weakness) in 2019.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, the patient experienced MYALGIA (Sore arm). At the time of the report, MYALGIA (Sore arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       no concomitant medication and treatment given
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: Pregnant; This spontaneous retrospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     Previously administered products included for Infertility: LETROZOLE (5 day treatment) in March 2021. Concurrent medical conditions included Drug allergy (celcor) and Drug allergy (sulfa). Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) for an unknown indication.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. The patient's last menstrual period was on 28-Feb-2021 and the estimated date of delivery was 05-Dec-2021. On an unknown date, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fifth week of the pregnancy. The delivery occurred  on 16-Mar-2021, which was reported as Outcome Pending. For foetus 1, The outcome was reported as Unknown. At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient has a history of alcohol use prior which included 1 to 2 glasses of wine per night with dinner and reduced since 11-Mar-2021 and stopped on 02-Apr-2021. The date of positive pregnancy test was 02-Apr-2021 and estimated date of conception was 16-Mar-2021. The mother needed to conceive using clomid and used letrozole twice for this pregnancy. The patient had received prenatal care. Concomitant product use was not provided by the reporter. Treatment information was not provided.   This case was linked to US-MODERNATX, INC.-MOD-2021-074215, US-MODERNATX, INC.-MOD-2021-074215 (E2B Linked Report). This case was linked to MOD-2021-208955 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 19-May-2021: Internal review on 20-JUL-2021 resulted in update in pregnancy details, medical history and the outcome.; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-074215:MOD21-069043 US-MODERNATX, INC.-MOD-2021-074215:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Dyspnoea, Feeling abnormal, Headache, Neck pain
Clinical narrative: Feeling like my brain was sweilling; long haul adverse reaction; made situation worse/My situation is getting worse; Shortness of breath; neck pain got worse; headache; neck pain; neck swelling; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling like my brain was sweilling), VACCINATION COMPLICATION (long haul adverse reaction), SWELLING (neck swelling), CONDITION AGGRAVATED (made situation worse/My situation is getting worse) and DYSPNOEA (Shortness of breath) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 217B21A and 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Parkinson's disease since July 2019. Concomitant products included CARBIDOPA, LEVODOPA (SINAMET) and ALPRAZOLAM (XANAX) for an unknown indication.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Jun-2021, the patient experienced SWELLING (neck swelling) and NECK PAIN (neck pain). On an unknown date, the patient experienced FEELING ABNORMAL (Feeling like my brain was sweilling), VACCINATION COMPLICATION (long haul adverse reaction), CONDITION AGGRAVATED (made situation worse/My situation is getting worse), DYSPNOEA (Shortness of breath), PAIN (neck pain got worse) and HEADACHE (headache). At the time of the report, FEELING ABNORMAL (Feeling like my brain was sweilling), VACCINATION COMPLICATION (long haul adverse reaction), SWELLING (neck swelling), CONDITION AGGRAVATED (made situation worse/My situation is getting worse), DYSPNOEA (Shortness of breath), NECK PAIN (neck pain), PAIN (neck pain got worse) and HEADACHE (headache) had not resolved.            No treatment information was provided.   This case was linked to MOD-2021-074208 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: AE added. Patient reported that her situation is getting worse. Patient can't access FU form on her Kindle and would like to be contacted personally. On 16-Jul-2021: Follow up received on 16 Jul 2021 contains no significant information.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Swelling, Vaccination complication
Clinical narrative: Feeling like my brain was sweilling; long haul adverse reaction; made situation worse/My situation is getting worse; Shortness of breath; neck pain got worse; headache; neck pain; neck swelling; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling like my brain was sweilling), VACCINATION COMPLICATION (long haul adverse reaction), SWELLING (neck swelling), CONDITION AGGRAVATED (made situation worse/My situation is getting worse) and DYSPNOEA (Shortness of breath) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 217B21A and 030A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Parkinson's disease since July 2019. Concomitant products included CARBIDOPA, LEVODOPA (SINAMET) and ALPRAZOLAM (XANAX) for an unknown indication.   On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 01-Jun-2021, the patient experienced SWELLING (neck swelling) and NECK PAIN (neck pain). On an unknown date, the patient experienced FEELING ABNORMAL (Feeling like my brain was sweilling), VACCINATION COMPLICATION (long haul adverse reaction), CONDITION AGGRAVATED (made situation worse/My situation is getting worse), DYSPNOEA (Shortness of breath), PAIN (neck pain got worse) and HEADACHE (headache). At the time of the report, FEELING ABNORMAL (Feeling like my brain was sweilling), VACCINATION COMPLICATION (long haul adverse reaction), SWELLING (neck swelling), CONDITION AGGRAVATED (made situation worse/My situation is getting worse), DYSPNOEA (Shortness of breath), NECK PAIN (neck pain), PAIN (neck pain got worse) and HEADACHE (headache) had not resolved.            No treatment information was provided.   This case was linked to MOD-2021-074208 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 09-Jul-2021: AE added. Patient reported that her situation is getting worse. Patient can't access FU form on her Kindle and would like to be contacted personally. On 16-Jul-2021: Follow up received on 16 Jul 2021 contains no significant information.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Oropharyngeal pain
Clinical narrative: sore throat; headache; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) and HEADACHE (headache) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced OROPHARYNGEAL PAIN (sore throat) and HEADACHE (headache). On 12-Apr-2021, OROPHARYNGEAL PAIN (sore throat) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant nor treatments medications were provided.    Reporter did not allow further contact
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy
Clinical narrative: pregnancy; This spontaneous prospective pregnancy case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of EXPOSURE DURING PREGNANCY (pregnancy) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On 02-Apr-2021, the patient experienced EXPOSURE DURING PREGNANCY (pregnancy). On 02-Apr-2021, EXPOSURE DURING PREGNANCY (pregnancy) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache
Clinical narrative: dizzy; terrible headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy) and HEADACHE (terrible headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1. On 09-Apr-2021, the patient experienced DIZZINESS (dizzy) and HEADACHE (terrible headache). At the time of the report, DIZZINESS (dizzy) and HEADACHE (terrible headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain
Clinical narrative: sore throat; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (sore throat) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 immunisation.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat). At the time of the report, OROPHARYNGEAL PAIN (sore throat) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient gargled with Listerine last night (11Apr2021) and the sore throat went away but returned the following day (12Apr2021).  Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Blood pressure increased, Blood pressure measurement, Fatigue, Headache, Heart rate
Clinical narrative: scratchy throat,; Fever; bad sweats during the night; Headache; Fatigue; high blood pressure; heart rate Increased; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 12-Apr-2021 and was forwarded to Moderna on 12-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (high blood pressure), HEART RATE INCREASED (heart rate Increased), HYPERHIDROSIS (bad sweats during the night), OROPHARYNGEAL PAIN (scratchy throat,) and HEADACHE (Headache) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CARVEDILOL and LOSARTAN for an unknown indication.   On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Apr-2021, the patient experienced BLOOD PRESSURE INCREASED (high blood pressure) and HEART RATE INCREASED (heart rate Increased). On 11-Apr-2021, the patient experienced HYPERHIDROSIS (bad sweats during the night). 11-Apr-2021, the patient experienced HEADACHE (Headache) and FATIGUE (Fatigue). On 12-Apr-2021, the patient experienced OROPHARYNGEAL PAIN (scratchy throat,) and PYREXIA (Fever). At the time of the report, BLOOD PRESSURE INCREASED (high blood pressure), HEART RATE INCREASED (heart rate Increased), HYPERHIDROSIS (bad sweats during the night), OROPHARYNGEAL PAIN (scratchy throat,), HEADACHE (Headache), FATIGUE (Fatigue) and PYREXIA (Fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Apr-2021, Blood pressure measurement: 145/95 (High) 145/95 mmHg. On 10-Apr-2021, Heart rate: 95 (High) 95 bpm. On 12-Apr-2021, Blood pressure measurement: 174/97 (High) 174/97mmHg. On 12-Apr-2021, Heart rate: 71 (normal) 71 bpm.         Action taken with mRNA-1273 in response to the drug was not applicable. No treatment medication information was provided.